Zyprexa Lawsuit Settlement, Zyprexa Settlement, Zyprexa Lawsuits

Zyprexa Settlement Funding

Cases Eligible for Lawsuit Funding
picture
Zyprexa Settlement Funding

Zyprexa Settlement Loans
Zyprexa Lawsuit Settlement 2011

Have a Settled Zyprexa Lawsuit? Need Cash NOW? Get $500 to $500K in 24-48 Hours! Blazing-Fast Approvals, Super-Low Rates, Bad Credit Is OK! Zyprexa Class Action, Zyprexa Settlement, Zyprexa Litigation Funding.

Atypical Anti-psychotics Drugs: There are 6 atypical antipsychotic meds are approved for use in the US:

Abilify® (Aripiprazole)
Manufacturer: Bristol Myers

Clozaril® (Clozapine)
Manufacturer: Novartis

Geodon® (Ziprasidone)
Manufacturer: Pfizer

Risperdal® (Risperidone)

Manufacturer: Janssen

Zyprexa® (Quetiapine)
Manufacturer: AstraZeneca

Zyprexa® (Olanzapine)
Manufacturer: Eli Lilly
Interested in hearing what some of our past clients have to say about their experience with TriMark Legal Funding LLC?

Read Client Testimonials

>> Visit Our Blog <<

Pre Settlement Loans
Lawsuit loans (also called pre settlement loans or lawsuit cash advances) are available on personal injury lawsuits and can provide you with the cash you need, when you need it, to keep your family safe from financial hardships.

Helpful Resources:

Zyprexa Class Action Lawsuit Is Now Eligible For Settlement Funding!

Zyprexa Lawsuit Funding | Zyprexa Lawsuit Loans | Zyprexa Settlement Funding
Settlement Advances for Plaintiffs Seriously Injured By Zyprexa Side Effects

Application
Please provide ALL information requested:

(xxx-xxx-xxxx)


Any Prior Advances?

NOTICE FOR WORKERS COMP CASES ONLY:
If you live in a state that is NOT on this Eligibility List, your application will be discarded.
Is This Workers Comp?




Failure to provide attorney's fax number WILL result in a lengthy processing delay!
Zyprexa Lawsuit Loans

September 1, 2006
TriMark Legal Funding LLC announced that it will offer lawsuit advances on settled Zyprexa lawsuits. Are you looking for lawsuit loans or lawsuit funding?

Of the six atypical antipsychotic medications approved by the FDA for use in the United States, Zyprexa is the most commonly prescribed. Zyprexa has been prescribed to more than 14 million people in 84 countries since 1996.

In September 2003, the FDA ordered Eli Lilly, the drug's manufacturer, to revise Zyprexa's label by adding a side effects warning that "hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical anti-psychotics." Other Zyprexa side effects can include diabetes, diabetic coma, diabetic ketoacidosis, hyperglycemia, hyperosmolar coma and death.

Zyprexa Lawsuit

Zyprexa Lawsuit Loans

Eli Lilly, a world leader in diabetes research, prior to marketing the drug in the US, had knowledge that the side effects of Zyprexa included diabetes, pancreatitis and severe weight gain. Nevertheless, they made the profit-driven decision to market the drug in 1996 without proper warnings to patients or doctors of these severe side effects.

The Zyprexa lawsuit is based on allegations that the Zyprexa label in use prior to March 2004 contained inadequate warnings regarding the seriousness of potential side effects.

Also, published reports indicate that as far back as the 1950's, studies tied the use of Zyprexa and similar drugs to an increased incidence of diabetes, pancreatitis, hyperglycemia and other serious conditions. It is alleged that Eli Lilly continued to market Zyprexa without adequate warnings, despite full knowledge of this vital information.

Eli Lilly and the Zyprexa Debacle
Tens of Thousand Negligently Injured; BILLIONS In Profits Earned By Eli Lilly

In February of 2004, the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity and the American Association of Clinical Endocrinologists issued a joint statement warning the public of the association between Zyprexa and serious weight gain, diabetes and pancreatitis.

Eli Lilly and the Zyprexa Settlement

Zyprexa Lawsuit Loans

At least 8,000 people have developed serious conditions like diabetes, pancreatitis (inflammation of pancreas), ketoacidosis, hyperglycemia, seizures, diabetic coma, stroke, heart attack, amputation of a limb (due to diabetes), severe weight gain and other medical conditions.

On January 14, 2009 Eli Lilly officially settled a portion of the Zyprexa lawsuit for $1.42 billion. Putting this into some context, Eli Lilly reportedly had Zyprexa sales in excess of $37 billion since the drug was first introduced, making it one of Eli Lilly's biggest sellers.

In the meantime, it is becoming commonplace for people who have been injured by Zyprexa to find themselves in need of extra money due to loss of income from being out of work to pay for bills, medical care & basic living expenses. Pre settlement funding or a lawsuit cash advance can give plaintiffs the money they need now to get by until their full settlement comes through, whenever that may be.

Getting lawsuit funding or a pre settlement advance is simple and easy. It's fast, free and easy to apply and with no credit checks, no income or employment requirements, no monthly payments and no up-front or out-of-pocket costs, settlement loans are 100% RISK-FREE for plaintiffs and you only repay the advance if you win your case. If you lose your case or your case doesn't settle, YOU OWE US NOTHING!

ZYPREXA LAWSUIT SETTLEMENT FUNDING IS 100% RISK-FREE ... SO WHY WAIT?

Does your Zyprexa lawsuit qualify for lawsuit funding? Call us at 1-877-932-2628 or apply online!

Apply

We purchase structured settlements and/or provide lawsuit cash advance services for Zyprexa lawsuits (settled cases ONLY) throughout the United States: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia (Washington DC).